Meet members of CHOC’s institutional review boards (IRB), who protect the rights and welfare of pediatric patients recruited to participate in studies.
UCI AI innovation challenge winners include students involved in pediatric research at CHOC
Students involved in CHOC’s Research Institute were on winning teams with projects utilizing AI to improve patient outcomes.
FDA approval grows use of growth therapy for children with achondroplasia
The most common type of dwarfism, achondroplasia can now be treated with Voxzogo starting at birth, maximizing children’s growth potential.
CHOC-affiliated blood disorder center administers landmark gene therapy infusion for hemophilia
The center becomes the first in the country to administer a commercial gene therapy infusion to treat Hemophilia A, the common disorder affecting males.
CHOC-led study reveals racial disparities in fatal encounters between youth and law enforcement
CHOC “lets the data speak for itself” in first-of-its-kind study into pediatric injuries sustained during law enforcement encounters.
Evaluating newer medications in the treatment of neonatal seizures; predicting future epilepsy risk after neonatal seizures
CHOC aims to improve care of neonatal seizures through research into medications with fewer side effects than traditional anti-epileptics.
